Clinical features and magnetic resonance image analysis of 15 cases of demyelinating leukoencephalopathy induced by levamisole

The aim of this study was to explore the diagnostic value of magnetic resonance imaging (MRI) for levamisole-induced demyelinating leukoencephalopathy. The clinical features and MRI findings of 15 patients with levamisole-induced demyelinating leukoencephalopathy were retrospectively analyzed. The a...

Full description

Saved in:
Bibliographic Details
Published in:Experimental and therapeutic medicine 2013-07, Vol.6 (1), p.71-74
Main Authors: YAN, RUIFANG, WU, QINGWU, REN, JIPENG, CUI, HONGKAI, ZHAI, KAIHUA, ZHAI, ZHANSHENG, DUAN, QINGHONG
Format: Article
Language:English
Subjects:
demyelinating leukoencephalopathy
Disease
Edema
Family medical history
Fever
levamisole
magnetic resonance imaging
Medical errors
Medical imaging
Metastasis
Morphology
NMR
Nuclear magnetic resonance
Patients
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to explore the diagnostic value of magnetic resonance imaging (MRI) for levamisole-induced demyelinating leukoencephalopathy. The clinical features and MRI findings of 15 patients with levamisole-induced demyelinating leukoencephalopathy were retrospectively analyzed. The abnormality rate of the patients was demonstrated to be 100% by MRI, and scattered multiple cerebral foci were observed in all of the patients. The majority of the foci were located at the centrum ovale, peri-lateral cerebral ventricles and basal ganglia, while the remainder were located in the brain stem and cerebellum, as well as in the white matter regions of the temporal, frontal, apical and occipital lobes. In addition, mottling and ring-shaped enhancements were observed. The study demonstrated that MRI effectively displays demyelinating leukoencephalopathy, and that the combination of MRI with the medical history of the patient is of significance for the early diagnosis, differentiation and treatment of demyelinating leukoencephalopathy.
ISSN:1792-0981
1792-1015
DOI:10.3892/etm.2013.1077